Sihua Gao

By
\"\"

Sihua Gao is among the first group of Qihuang Scholars, a nationally renowned TCM physician, and a famous TCM doctor in Beijing. He holds a Ph.D. in medicine and serves as a doctoral supervisor. Gao is a chief expert and second-level professor at Beijing University of Chinese Medicine. He is a mentor for the academic experience inheritance of national veteran TCM experts and has served as the chief scientist for the TCM special project of the National 973 Program. He is a central leadership health consultation expert. Additionally, he has been recognized as the chief health science expert of the Chinese Medicine Association and an influential figure in TCM science popularization, as well as the \”Glorious Doctor\” and \”Top Ten Medical Experts with Outstanding Contributions\” in public evaluations.
Sihua Gao is among the first graduates to earn a master\’s degree and a doctoral degree in TCM in China, having studied under renowned TCM experts Professor Zhang Zhenyu and Professor Fang Yaozhong. He has studied abroad in Japan and the UK. He has previously served as the director of the Graduate Department and vice president of the China Academy of Chinese Medical Sciences; the director of the Department of Science and Education and the Department of Science and Technology of the State Administration of Traditional Chinese Medicine; and the president of Beijing University of Chinese Medicine.
He has also held concurrent positions as vice president of the Chinese Medicine Association, the Chinese Association of Integrative Medicine, the China Health Care Association, the China Medicinal Cuisine Research Association, and the Chinese Society of Geriatric Health Medicine.
Currently, he is the president of the Chinese Medical Qigong Association; vice president of the Internal Medicine, Diabetes, and Music Therapy branches of the World Federation of Chinese Medicine Societies; chairman of the Chronic Disease Conditioning Committee of the China Medicinal Cuisine Research Association; chairman of the Women and Children\’s Dietary Therapy Committee of the China Eugenics and Genetics Association; honorary chairman of the Endocrinology Committee of the Chinese Association of Integrative Medicine; and honorary chairman of the Diabetes Committee of the Chinese Medicine Association.
Sihua Gao has been passionate about martial arts since childhood and is a seventh-generation inheritor of Yang-style Tai Chi. He has been practicing Qigong for over 30 years and has deep insights into using Qigong for health maintenance and disease prevention.
He specializes in the clinical diagnosis and treatment of complex diseases such as diabetes, thyroid diseases, endocrine disorders, cardiovascular and cerebrovascular diseases, and kidney diseases. He has been invited multiple times to provide medical consultations and lectures in Thailand, the United States, Japan, the United Kingdom, Australia, Hong Kong, and other countries and regions. He has also been invited to provide medical care and health consultations for foreign dignitaries, including the Queen of Bahrain and the President of Kazakhstan.

Topic: Research on the Intervention of Baduanjin Qigong in Type 2 Diabetes

Objective: To investigate the clinical effects of Baduanjin Qigong on type 2 diabetes (T2D) patients.
Methods: This study enrolled T2D patients aged 40-75 years with poorly controlled blood glucose and high dysfunctional attitude scores. Participants were randomly assigned to two groups, receiving a 12-week intervention of Baduanjin Qigong or the eighth set of radio calisthenics, respectively. Blood levels of C-peptide, glycated hemoglobin, leptin, adiponectin, free fatty acids, total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were measured before and after the intervention. Additionally, the Self-Rating Depression Scale (SDS), Dysfunctional Attitude Scale (DAS), Automatic Thoughts Questionnaire (ATQ), and WHO Quality of Life-BREF (WHOQOL-BREF) were used to evaluate depressive symptoms, dysfunctional attitudes, negative automatic thoughts, and life quality, respectively. The differences between the two groups post-intervention, as well as the changes within each group before and after the intervention, were analyzed. Participants maintained their basic treatment regimens throughout the study.
Results: The 12-week intervention with Baduanjin Qigong significantly improved insulin sensitivity, reduced total cholesterol, and showed a trend toward lowering HbA1c levels in T2D patients. The intervention also ameliorated both general and specific depressive symptoms, enhanced quality of life, and positively influenced deep-seated negative cognitions related to depression. Moreover, Baduanjin Qigong significantly improved mental tranquility and satisfaction with social interactions, affecting deeper levels of negative cognition.
Conclusion: Regular practice of Baduanjin Qigong offers significant benefits for glucose metabolism and mental health in T2D patients, proving to be an effective exercise therapy for managing T2D.